BTCY240816C2500
- 0.05
- -0.04-44.44%
Biotricity Newsroom
Biotricity Analyst Ratings
Analysts Offer Insights on Healthcare Companies: Mainz Biomed B.V. (MYNZ), Xencor (XNCR) and Biotricity (BTCY)
Analysts' Top Healthcare Picks: Legend Biotech (LEGN), Biotricity (BTCY)
Update: HC Wainwright Adjusts Biotricity Price Target to $4 From $12 After 1-for-6 Reverse Stock Split, Maintains Buy Rating
H.C. Wainwright Sticks to Their Buy Rating for Biotricity (BTCY)
HC Wainwright Adjusts Biotricity Price Target to $4 From $12, Maintains Buy Rating
HC Wainwright & Co. Reiterates Buy on Biotricity, Raises Price Target to $4
Analysts' Top Technology Picks: Weibo (WB), Biotricity (BTCY)
Biotricity Analyst Ratings
HC Wainwright & Co. Reiterates Buy on Biotricity, Maintains $2 Price Target
H.C. Wainwright Sticks to Its Buy Rating for Biotricity (BTCY)
Analysts Offer Insights on Technology Companies: II-VI (IIVI), Biotricity (BTCY) and Otonomo Technologies (OTMO)
H.C. Wainwright Sticks to Its Buy Rating for Biotricity (BTCY)
Biotricity Cut to Hold From Buy by Maxim Group
Lake Street Adjusts Biotricity Price Target to $4 From $5, Maintains Buy Rating
HC Wainwright Adjusts Biotricity's Price Target to $2 from $6, Keeps Buy Rating
Biotricity Is Maintained at Buy by HC Wainwright & Co.
Biotricity Price Target Cut to $2.00/Share From $6.00 by HC Wainwright & Co.
HC Wainwright & Co. Maintains Buy on Biotricity, Lowers Price Target to $2
Biotricity analyst ratings